Patents Represented by Attorney Amser, Rothstein & Ebenstein
  • Patent number: 8338464
    Abstract: Provided are methods of inhibiting BCL6 repression in a mammalian cell. Also provided are methods of treating cancer in a mammal.
    Type: Grant
    Filed: November 29, 2007
    Date of Patent: December 25, 2012
    Assignees: Albert Einstein College of Medicine of Yeshiva University, University Health Network, University of Maryland, Baltimore
    Inventors: Ari Matthew Melnick, Alexander D. MacKerell, Jr., Gilbert Gerard Privé